Researchers Identify Gene Linking Specific Immune Cells to Gastric Cancer Progression
A study using spatial transcriptomics and machine learning highlights the role of SERPINE1 in tumor stromal remodeling.
Key takeaways
- Researchers identified five distinct macrophage subclusters in gastric cancer, linking the macro_SPP1 and macro_IL1B signatures to shorter overall survival.
- The gene SERPINE1 was identified as a consistent prognostic marker associated with poor survival and prominent stromal, myeloid, and vascular features.
- Spatial analysis showed that high SERPINE1 expression localized to microenvironments rich in fibroblast and endothelial components, as well as extracellular matrix remodeling programs.
- Laboratory knockdown of SERPINE1 in gastric cancer cells reduced cell proliferation, colony formation, migration, and invasion.
Researchers studying the gastric cancer tumor microenvironment have identified a specific gene, SERPINE1, as a potential key link between specialized immune cells and the structural remodeling of tumor tissue. The finding, published in the journal BioFactors (Oxford, England) in September 2026, provides new insights into how macrophage diversity influences patient outcomes and tumor behavior.
To understand the complex cellular interactions within gastric tumors, researchers integrated single-cell RNA sequencing data, spatial transcriptomic data, and bulk transcriptomic data from public registries. This multi-layered analysis allowed the team to map out how different subclusters of macrophages—a type of immune cell—interact with surrounding tumor stroma and impact survival rates.
By combining macrophage marker genes with tumor-specific differentially expressed genes and applying machine learning models, the study singled out SERPINE1 as a consistent prognostic candidate. High expression of this gene was strongly associated with poorer survival outcomes and distinct structural and vascular changes within the tumor microenvironment.
What Happened
Mapping Macrophage Subclusters and Cellular Signaling
In the study published in BioFactors, researchers analyzed data from three distinct datasets: single-cell RNA sequencing data (GSE183904), spatial transcriptomic data (GSE251950), and bulk transcriptomic data from The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD) registry.
The analysis revealed five distinct subclusters of macrophages. Among these, two specific signatures—labeled macro_SPP1 and macro_IL1B—were associated with shorter overall survival in patients. Conversely, a subcluster labeled macro_C3_CX3CR1 was linked to more favorable survival outcomes.
Cell-to-cell communication modeling showed intensified signaling pathways within the tumors, particularly involving MIF, COLLAGEN, FN1, LAMININ, and SPP1. To pinpoint the most clinically relevant molecules, the researchers integrated the genetic markers of the high-risk macro_SPP1 subcluster with other differentially expressed genes in gastric tumors. Using Cox regression and machine learning algorithms, the team identified the gene SERPINE1 as a primary driver and prognostic marker.
What The Evidence Shows
Molecular Interactions and Cellular Knockdown Results
The study's findings are backed by spatial and laboratory analyses:
Spatial Localization: Spatial transcriptomic analysis showed that regions with high SERPINE1 expression were physically located in microenvironments enriched with fibroblast- and endothelial-related components. These regions also showed heightened activity in molecular programs associated with TGF-beta, hypoxia, inflammation, and extracellular matrix remodeling.
Virtual Perturbation: Computer-based simulations suggested that altering SERPINE1 expression could directly influence transcriptional networks related to myeloid cells and the cellular matrix.
Functional Knockdown: In laboratory cell lines, knocking down the SERPINE1 gene led to a measurable reduction in gastric cancer cell proliferation, colony formation, migration, and invasive behavior.
What We Don't Know Yet
What the Study Does Not Address
While the findings identify a correlation between SERPINE1, macro_SPP1 macrophages, and poor outcomes, several limitations remain. The primary source does not report the specific patient sample sizes from the analyzed datasets, nor does it state the clinical stages of the patients from whom the samples were originally derived. Because much of the study relied on retrospective data analysis and virtual perturbation models, the clinical utility of targeting SERPINE1 in human patients remains unproven. The published source does not discuss further limitations of the research methods.
What Comes Next
Open Questions for Future Research
The published study leaves several questions open for future investigation. It is not yet known whether these findings can be replicated in large-scale prospective clinical trials, or if therapeutic agents targeting SERPINE1 can safely and effectively reduce tumor growth or remodeling in patients. The primary source does not outline specific plans or next steps for the research team.
What This Means
A Potential Biomarker for Aggressive Disease
The identification of SERPINE1 as a link between macro_SPP1 macrophages and stromal remodeling suggests that this gene could serve as a valuable biomarker for identifying patients with more aggressive gastric cancer. It highlights how specific immune cell subclusters do not act in isolation but instead coordinate with the surrounding stroma to promote malignant behaviors like cell migration and invasion. This molecular connection offers a potential avenue for future research into therapies that disrupt the supportive environment of the tumor.
Original Source
PubMed (NCBI E-utilities): https://pubmed.ncbi.nlm.nih.gov/42698055/
Questions readers ask
- What is the main finding of the study on gastric cancer?
- The study identified the gene SERPINE1 as a key prognostic marker that links specific immune cells, known as macro_SPP1 macrophages, to the remodeling of tumor stroma. High expression of SERPINE1 was associated with shorter overall survival in patients.
- Which macrophage subclusters are associated with patient survival?
- The study resolved five macrophage subclusters. The signatures for macro_SPP1 and macro_IL1B were associated with shorter overall survival, while the macro_C3_CX3CR1 signature was associated with a more favorable outcome.
- How does SERPINE1 affect gastric cancer cells in laboratory tests?
- In functional laboratory experiments, knocking down the SERPINE1 gene in gastric cancer cells reduced their proliferation, colony formation, migration, and ability to invade tissues.
What this means
A Potential Biomarker for Aggressive Disease The identification of SERPINE1 as a link between macro_SPP1 macrophages and stromal remodeling suggests that this gene could serve as a valuable biomarker for identifying patients with more aggressive gastric cancer. It highlights how specific immune cell subclusters do not act in isolation but instead coordinate with the surrounding stroma to promote malignant behaviors like cell migration and invasion. This molecular connection offers a potential avenue for future research into therapies that disrupt the supportive environment of the tumor.
Limitations and uncertainties
- What the Study Does Not Address
- While the findings identify a correlation between SERPINE1, macro_SPP1 macrophages, and poor outcomes, several limitations remain. The primary source does not report the specific patient sample sizes from the analyzed datasets, nor does it state the clinical stages of the patients from whom the samples were originally derived. Because much of the study relied on retrospective data analysis and virtual perturbation models, the clinical utility of targeting SERPINE1 in human patients remains unproven. The published source does not discuss further limitations of the research methods.
